Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $107
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $93 to $107.
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $93 to $107.